Functional neurological disorder (FND) is increasingly recognized in older adults, although it remains underdiagnosed in this age group. Historically, research and clinical attention have focused on younger and middle-aged populations, which has contributed to the misconception that FND is rare in later life. More recent hospital-based and community-based studies suggest that FND accounts for a meaningful proportion of neurological presentations in older age, especially in emergency departments and general neurology clinics.
Estimates of prevalence vary widely due to differences in diagnostic criteria, study design, and setting, but FND is consistently found among the top causes of unexplained neurological symptoms across the adult lifespan. In specialized movement disorder and seizure clinics, functional symptoms may represent 10–20% or more of new referrals, and a smaller yet significant fraction of these patients are over 65 years old. Some cohort studies indicate that the proportion of patients with FND who are in later life is growing, partly because of demographic aging and greater clinician awareness.
Age-stratified analyses show that FND in older adults is probably underrepresented in prevalence statistics. Misclassification as stroke, neurodegenerative disease, or medication side effects is frequent, skewing epidemiological data. In stroke units, for example, functional stroke mimics may account for 5–15% of admissions; a notable subset of these patients are older, but they are not always coded or followed as having FND. Similar patterns appear in epilepsy services, where functional seizures are sometimes incorrectly attributed to late-onset epilepsy or metabolic encephalopathy.
Diagnostic coding practices contribute further to uncertainty. Many healthcare systems still lack precise codes for FND subtypes, and clinicians may select broader symptom-based or psychiatric diagnoses instead. This is particularly common in geriatric care, where diagnostic labels such as “conversion disorder,” “somatization,” or nonspecific “gait disorder” may be used instead of FND, limiting the reliability of administrative data. As a result, true prevalence in older age is likely higher than published figures suggest.
The demographic profile of older adults with FND often differs from that of younger patients. Older individuals with FND may have a higher burden of medical comorbidity, including cardiovascular disease, diabetes, chronic pain, and musculoskeletal problems. These conditions can both mask and mimic functional symptoms, delaying accurate identification. They may also influence pathways to care: patients with multiple chronic illnesses are more likely to have frequent contact with healthcare services, increasing the opportunity for FND to present, but also increasing the likelihood that symptoms are ascribed to existing conditions rather than recognized as functional.
Population aging means that the absolute number of older people with FND is poised to rise. Even if age-specific incidence remains stable, the larger pool of older adults will translate into increased clinical and public health impact. Over time, this may shift the age distribution of FND in clinical practice, with more cases detected in the seventh, eighth, and ninth decades of life. The trend is already visible in longitudinal service data from some countries, where referrals for FND among people over 65 have increased in parallel with geriatric neurology and psychiatry referrals overall.
Gender patterns in FND appear to persist into later life, with women more frequently diagnosed than men, although the gap may narrow somewhat with advancing age. Social and cultural factors, patterns of help-seeking, and differential survival could all influence these observations. Existing epidemiological studies rarely explore gender, ethnicity, and socioeconomic status in older cohorts with sufficient detail, leaving important questions about disparities in recognition and treatment unanswered.
Healthcare setting plays a major role in observed prevalence. In inpatient geriatric units and acute medical wards, FND may present as sudden weakness, falls, gait disturbance, or acute changes in speech and swallowing, leading to workups for stroke or other acute neurological events. In these environments, functional presentations can represent a sizable minority of “negative workup” cases. In outpatient geriatric clinics, FND may be more commonly seen as chronic imbalance, tremor, or unexplained episodes of unresponsiveness, yet these are often attributed to aging, medication effects, or dementia rather than systematically classified as functional.
Emergency departments are another key locus where prevalence is observable. Older adults frequently present with acute neurological symptoms that turn out not to have an identifiable structural cause. Among these, functional stroke and seizure mimics constitute an important subgroup. While precise percentages vary, many emergency and hyperacute stroke services report that functional presentations constitute a nontrivial fraction of code-stroke activations in people over 60, underscoring FND’s relevance to acute care planning and resource allocation.
Cognition and mood are important epidemiological correlates in this age group. Late-life depression, anxiety, prolonged stress, bereavement, and social isolation are all more common among older individuals and tend to cluster with FND. Additionally, subtle cognitive changes—whether due to normal aging, mild cognitive impairment, or early dementia—may complicate clinical assessment and contribute to misdiagnosis. Symptoms that are actually functional can be misinterpreted as evidence of an evolving neurodegenerative process, concealing the true prevalence of FND.
Mobility-related functional symptoms, such as functional gait disorder and functional weakness, may be particularly prominent in older populations and hold special epidemiological significance because of their association with falls, fractures, and institutionalization. Falls are a leading cause of morbidity and healthcare utilization in later life, and functional gait disturbance may be an unrecognized contributor in a subset of these cases. Consequently, FND in older adults may exert a disproportionate impact on hospitalization rates, length of stay, and need for long-term care compared with its apparent numerical prevalence.
The interplay between FND and polypharmacy is also epidemiologically relevant. Older adults frequently use multiple medications, raising the risk of adverse drug effects that can mimic or interact with functional symptoms. This can create diagnostic confusion, causing FND to be either overestimated (when drug side effects are misclassified as functional) or underestimated (when functional symptoms are attributed to medication toxicity). The presence of polypharmacy also marks patients as clinically complex, and this complexity is one reason FND in later life tends to be concentrated in tertiary care and specialist geriatric or neuropsychiatric services.
Service-use studies show that older people with FND often have high rates of healthcare utilization, including repeated imaging, specialist consultations, and hospital admissions. These patterns mirror those seen in younger adults with FND but can be amplified by age-related vulnerabilities, additional diagnostic workups for comorbid illness, and a lower clinical threshold for admission and observation. As more clinicians recognize FND as a legitimate and common diagnosis in older adults, there is potential for earlier identification, more efficient use of investigations, and more targeted referral to rehabilitation services and psychological interventions.
Across healthcare systems, recognition of FND in older age remains uneven. Centers with specialized FND clinics or integrated neuropsychiatry and geriatric services tend to report higher detection rates, suggesting that prevalence is partly a function of clinician training and system-level readiness to identify functional symptoms. In regions or settings where such expertise is scarce, the condition is more likely to go undocumented or be subsumed under broader categories, perpetuating the impression that FND is predominantly a disorder of younger adults.
Current epidemiological knowledge is shaped by the limitations of existing research, which has rarely focused specifically on older adults. Many studies aggregate data across wide age ranges or set upper age limits that exclude the oldest old, leaving a gap in understanding of FND in people over 80 or 85. Moreover, most available data come from high-income countries, and very little is known about how FND presents and is managed in older populations in low- and middle-income settings. Cultural beliefs about aging, illness, and mental health may significantly alter patterns of help-seeking, labeling, and diagnosis, further obscuring global prevalence estimates.
Despite these gaps, the accumulating evidence indicates that FND should be regarded as a relatively common and clinically important cause of neurological symptoms in older adults, rather than a rarity. The combination of demographic trends, high comorbidity burden, frequent mobility problems, and substantial healthcare utilization underscores the need to better quantify and monitor the epidemiology of FND in later life. Improved case identification, standardized diagnostic criteria, and longitudinal cohort studies that include the full age spectrum are essential for more accurate prevalence estimates and more informed planning of specialized services and multidisciplinary rehabilitation programs tailored to this population.
Clinical presentation and diagnostic challenges
In later life, functional neurological symptoms often emerge against a dense background of medical, psychological, and social complexity, which shapes how they appear and how they are interpreted. Presentations can be acute, subacute, or chronic, and they frequently resemble common age-related neurological disorders. Because stroke, neurodegenerative disease, and metabolic disturbances are more prevalent in older adults, the threshold for suspecting FND may be high, and functional symptoms are often assumed to be manifestations of existing disease rather than a distinct diagnosis.
Motor symptoms are among the most prominent clinical features. Functional weakness may present suddenly, with hemiparesis, paraparesis, or monoparesis that mimics an ischemic stroke or transient ischemic attack. Older individuals may report that a limb has “given way” or feels “dead,” often in the context of stress, minor injury, or a seemingly trivial event such as standing from a chair. On examination, inconsistencies are characteristic: strength may vary with distraction or be normal when tested in a different context, and classic signs such as Hoover’s sign may be present. Yet, in busy acute settings, these nuances are easy to overlook, and an older patient with vascular risk factors may be managed under a stroke pathway before FND is considered.
Functional gait disorders are especially significant due to their relationship with falls and loss of independence. Patients may exhibit sudden onset of imbalance, knee buckling, “walking on ice,” or an erratic, non-physiological gait pattern that does not fit typical cerebellar, parkinsonian, or sensory ataxic syndromes. There may be disproportionate fear of falling and dramatic swaying without actual falls during examination, but frequent falls in daily life. Because gait disturbance is so common in late life, clinicians may attribute these patterns to arthritis, peripheral neuropathy, visual impairment, or aging itself, missing signs of internal inconsistency and the potential for targeted rehabilitation.
Functional tremor and other movement phenomena can also present de novo in older adults. Tremor may fluctuate markedly with attention, change in frequency or distribution, or disappear with distraction. Functional myoclonus, dystonia, or parkinsonism-like symptoms may appear, further complicating the differential diagnosis with essential tremor, Parkinson’s disease, or drug-induced movement disorders. Polypharmacy can obscure the picture: a new antipsychotic or antiemetic may plausibly explain abnormal movements, and clinicians may stop at medication review without probing for functional features such as entrainment of tremor or variability across tasks.
Functional seizures, or dissociative attacks, frequently pose diagnostic challenges in later life. Episodes may involve unresponsiveness, staring, shaking, or apparent syncope, often triggered by stress or occurring in medical settings. In older adults, they are frequently misattributed to late-onset epilepsy, syncope, transient ischemic attacks, or metabolic disturbances. Cognitive screening abnormalities, common in this age group, can reinforce the assumption of organic disease. Long-term video-EEG monitoring, the gold standard for distinguishing functional from epileptic events, may be less accessible or underutilized in frail patients, leading to prolonged use of antiseizure medications that provide no benefit and can exacerbate fatigue, confusion, and falls.
Speech and swallowing symptoms are another frequent presentation. Patients may develop sudden dysarthria, aphonia, or stuttering that lacks the anatomical or vascular pattern expected in stroke or structural lesions. Functional dysphagia can involve a sense of throat closure, difficulty initiating swallowing, or fear of choking, sometimes following a minor choking episode or procedure. In older individuals with known cerebrovascular disease or degenerative conditions, these functional symptoms are often presumed to be progressive manifestations of an existing diagnosis, which can lead to unnecessary dietary restrictions, tube feeding, and institutionalization.
Sensory symptoms may include hemisensory loss, non-dermatomal numbness, or altered sensation that does not map to a peripheral nerve, root, or cortical pattern. In older populations, these complaints are commonly blended with neuropathy, radiculopathy, or spinal stenosis, and the functional nature may not be recognized unless a detailed and methodical examination is performed. Pain, including functional limb pain and medically unexplained back or neck pain, may co-occur, further complicating the attribution of symptoms and the design of treatment plans.
Cognitive complaints are particularly complex in FND among older adults. Individuals may report “brain fog,” fluctuating memory lapses, and difficulty concentrating that do not fit early Alzheimer’s disease or other well-defined dementias. Mood disorders, sleep problems, chronic pain, and medication side effects often coexist, each capable of affecting cognition. Neuropsychological testing may reveal an inconsistent pattern: significant deficits in some sessions and near-normal performance in others, or a mismatch between severe subjective complaints and relatively preserved objective performance. However, the high prevalence of mild cognitive impairment and dementia in this age group can lead clinicians to overinterpret modest test abnormalities as evidence of degenerative disease, overshadowing a functional contribution.
Psychological and somatic symptoms typically intertwine with the neurological picture. Anxiety, depression, post-traumatic stress, and prolonged grief are common, particularly after bereavement, illness, or caregiving stress. Somatic preoccupation and health anxiety may be heightened by prior serious illness or experiences of seeing peers become disabled. Yet, mental health symptoms might be subtle or underreported due to stigma, generational attitudes, or a focus on “physical” complaints. When emotional distress is recognized, it is sometimes seen merely as a reaction to disability rather than a factor in symptom generation and maintenance, which can delay recognition of FND.
Clinical assessment in this population is complicated by comorbidity at multiple levels. Multiple chronic conditions—such as diabetes, cardiac disease, arthritis, and prior strokes—create overlapping symptom burdens and plausible organic explanations for new neurological complaints. Sensory loss, hearing and visual impairment, frailty, and reduced mobility can limit the quality of examination and communication. These factors may predispose clinicians to anchor on familiar diagnoses and overlook the distinctive internal inconsistencies that define FND. The result is a pattern of over-investigation and under-recognition, with repeated imaging and laboratory tests yielding little explanatory value.
Diagnostic overshadowing is a persistent issue. When a patient carries a label of dementia, Parkinson’s disease, or previous stroke, new functional symptoms are often folded into that diagnosis, especially if imaging shows chronic changes such as small-vessel ischemia or atrophy that are common in aging. Conversely, in patients with a history of psychiatric illness, new neurological symptoms may be dismissed as “just anxiety” or “behavioral,” without a structured assessment for FND. Both tendencies can prevent timely, accurate diagnosis and appropriate management.
Establishing the diagnosis requires a positive, rule-in approach rather than a diagnosis of exclusion. The emphasis is on identifying reproducible clinical signs that are internally inconsistent or incongruent with known neurological disease. In older adults, this means actively looking for features such as variability with distraction, non-anatomical distributions, and improvement with suggestion, while still ensuring that serious conditions like stroke, infection, and metabolic derangements are adequately excluded. Because many older patients present to emergency departments or acute care units, clinicians must balance the need for rapid triage with thoughtful bedside examination that can reveal functional signs.
Communication of the diagnosis brings its own challenges. Older individuals may have long-standing beliefs about illness that prioritize structural explanations and may associate functional or psychological terms with stigma or personal weakness. Hearing impairment, cognitive changes, and time-limited consultations can impede nuanced discussions. Clinicians may feel uncertain about how to explain FND in a way that validates symptoms, acknowledges real distress and disability, and avoids implying that the problem is imagined. When explanations are rushed, contradictory, or overly focused on “nothing wrong on the scan,” patients can feel dismissed, leading to repeated consultations and ongoing diagnostic shopping.
Differences in generational attitudes toward mental health can further complicate acceptance of the diagnosis. Some older adults may reject psychological formulations outright, preferring to seek additional physical tests or specialist opinions. Others may accept psychological involvement but fear being labeled as having a psychiatric disorder, especially if they have witnessed institutionalization or stigma in their lifetime. Effective explanation often requires framing FND as a problem at the intersection of brain, body, and life stressors, emphasizing that symptoms are genuine and potentially reversible through targeted rehabilitation and self-management strategies.
Another diagnostic challenge lies in documentation and coding. Clinicians may recognize a functional component but record vague labels such as “non-organic,” “medically unexplained,” or “anxiety-related,” without specifying FND or its subtype. This undermines continuity of care, as subsequent providers may misinterpret prior assessments and restart lengthy organic workups. For older adults, who often see multiple specialists across fragmented care systems, inconsistent documentation can lead to redundant investigations, conflicting explanations, and a sense of confusion or mistrust.
Access to specialized assessment tools also influences diagnostic accuracy. Video-EEG monitoring, detailed gait analysis, and comprehensive neuropsychological testing are not always available or feasible, particularly for frail patients or those living in long-term care. Even when tests are performed, interpretive expertise may be limited. For example, subtle FND-compatible inconsistencies in movement or cognition may be overlooked if the assessor is not familiar with age-specific presentations. Telemedicine can partly mitigate geographic barriers, but remote examination has its own limitations when assessing gait, balance, and fine motor signs in older adults.
The time course of symptom evolution can blur diagnostic boundaries. An older patient may initially present with clearly functional symptoms that, over years, coexist with or evolve into organic disease, or vice versa. A person with established Parkinson’s disease may later develop superimposed functional gait disturbance; an individual with early dementia may have long-standing functional cognitive symptoms. Distinguishing functional from organic elements in such mixed presentations is demanding but critical, as functional components may respond well to appropriately tailored rehabilitation even when structural pathology is also present.
Interaction with comorbidities and polypharmacy
The interaction between functional neurological symptoms and the broader medical profile of older adults is often complex, bidirectional, and self-reinforcing. In this age group, FND rarely exists in isolation; it typically emerges within a dense web of comorbidity, chronic symptoms, prior injuries, and medications. Understanding these interrelationships is essential for accurate diagnosis, risk stratification, and the design of realistic treatment plans.
Multiple chronic conditions shape both the onset and the expression of functional symptoms. Cardiovascular disease, diabetes, peripheral vascular disease, chronic obstructive pulmonary disease, arthritis, osteoporosis, and chronic pain syndromes are all common and contribute to reduced reserve, fatigue, and vulnerability to stress. When FND develops in this context, it may attach itself to pre-existing areas of weakness or pain—for example, functional leg weakness in someone with osteoarthritis of the knee, or functional gait disturbance in someone with mild neuropathy. The brain’s attentional and predictive systems may fixate on previously injured or symptomatic body regions, amplifying perception and contributing to maladaptive movement patterns.
Prior neurological events, such as stroke, transient ischemic attacks, head injury, or spinal surgery, are particularly influential. Older adults with a history of these conditions are more likely to attribute new or fluctuating symptoms to further structural damage, and healthcare professionals may share this bias. At the same time, these prior events can act as “anchors” for functional symptoms: an individual who has recovered from a minor stroke may later develop functional weakness or imbalance in the same limb or side of the body. In such cases, organic and functional elements intertwine, complicating clinical reasoning and often leading to repeated imaging and consultations without clear conclusions.
Mobility is a central area where comorbid conditions, FND, and aging intersect. Arthritis, sarcopenia, sensory loss, vestibular dysfunction, and visual impairment all contribute to unstable gait and a genuine risk of falls. A functional gait disorder can arise on top of this vulnerability, characterized by exaggerated instability, freezing, or knee buckling in specific contexts. Fear of falling, which is common after even a single fall, further heightens attention to every bodily sensation and movement, reinforcing maladaptive patterns. This interaction can rapidly accelerate functional decline: a person who was previously active may become housebound, avoid walking without assistance, and rely increasingly on mobility aids, even when their strength and balance are potentially improvable through targeted rehabilitation.
Chronic pain is another frequent comorbid condition that interacts with FND. Persistent back, neck, or limb pain—especially when only partially explained by imaging—can lead to guarded movements, disuse, and altered body schema. Functional weakness, tremor, or dystonia may emerge in the painful limb, and patients may develop strong beliefs that rest and avoidance are the only safe strategies. Analgesic regimens, including opioids, gabapentinoids, and muscle relaxants, may briefly reduce distress but also contribute to sedation, dizziness, and cognitive slowing, blurring the clinical picture. Over time, a cycle can develop in which pain, fear of movement, and functional motor symptoms mutually reinforce one another, leading to sustained disability.
Mental health conditions are highly prevalent in later life and exert significant influence on FND. Depression, anxiety disorders, post-traumatic stress, and prolonged grief following bereavement can all lower thresholds for symptom emergence and worsen coping. For instance, an older caregiver managing a spouse’s dementia may develop functional tremor or gait disturbance during a period of exhaustion and sleep deprivation. Yet, depression may be misattributed to physical illness, and anxiety may present with somatic complaints rather than overt emotional distress, especially among those who are reluctant to discuss psychological symptoms. This underrecognition can delay interventions that might stabilize mood, reduce arousal, and indirectly ameliorate functional symptoms.
Polypharmacy is a pervasive feature of late-life care and has particularly intricate interactions with FND. Older adults frequently take antihypertensives, anticoagulants, antidiabetics, statins, analgesics, psychotropics, and multiple over-the-counter preparations. Many of these medications can cause or exacerbate dizziness, fatigue, confusion, tremor, or gait instability. When new functional symptoms emerge, they may be attributed entirely to drug effects, leading clinicians either to stop short of considering FND or to attempt serial medication changes without addressing the functional component. Conversely, once FND is suspected, there is a risk that genuine adverse drug reactions will be dismissed as “just functional,” exposing patients to preventable harm.
Some medications are prescribed as a result of misdiagnosis of functional symptoms themselves. Older adults with functional seizures may receive antiseizure drugs for years; those with functional parkinsonism may be placed on dopaminergic therapy; individuals with functional dizziness may be given vestibular suppressants or sedatives. These treatments are typically ineffective for the functional aspect of the presentation and can worsen balance, cognition, and overall function. In this way, FND and polypharmacy become mutually reinforcing: misinterpretation of symptoms leads to unnecessary medications, which then generate new side effects and diagnostic confusion.
Cognition plays a fundamental role in the interaction between FND and comorbidities. Even mild cognitive changes related to aging, vascular disease, or early neurodegeneration can reduce flexibility of thinking, impair error monitoring, and make it harder to reinterpret bodily sensations in a less threatening way. People with memory impairment may have difficulty retaining explanations of FND, remembering diagnostic tests and their results, or following complex self-management strategies. At the same time, functional cognitive symptoms—such as fluctuating attention, retrieval difficulties, or striking inconsistencies in performance—can coexist with or be mistaken for early dementia. This overlap often leads to either overestimation or underestimation of organic pathology, with major implications for prognosis, advance care planning, and access to services.
Sleep disorders, including insomnia, sleep apnea, and restless legs syndrome, are common comorbidities that further modulate the FND picture. Chronic sleep deprivation impairs attention, heightens pain sensitivity, and increases emotional reactivity, all of which can amplify functional symptoms. Medications used to treat sleep problems, such as sedative-hypnotics, may increase falls risk and exacerbate daytime confusion. For an older adult with FND-related gait disturbance, the addition of even mild sedative burden can tip the balance toward recurrent falls and hospitalization. Addressing sleep quality and reviewing sedating medications can therefore be a critical, yet often overlooked, component of FND management.
Cardiovascular and autonomic conditions—such as orthostatic hypotension, atrial fibrillation, and heart failure—also interact with functional symptoms. For instance, episodes of dizziness or near-syncope may be partly organic but become embellished or perpetuated through functional mechanisms, resulting in dramatic collapses without clear physiological correlates during monitoring. The fear of “another attack” can lead to avoidance of standing, walking, or leaving home, compounding deconditioning and social isolation. Care teams must navigate carefully between legitimate concern about cardiovascular risk and recognition of functional contributions that are amenable to rehabilitation.
Frailty and sarcopenia intensify these interactions. As physical reserves diminish, each additional problem—whether a new medication, minor infection, or functional exacerbation—can have outsized impact on independence. A transient worsening of functional weakness after stress or illness may prompt prolonged bed rest, which then accelerates muscle loss and makes recovery more difficult. Likewise, the presence of FND can distort assessments of frailty: someone may appear severely disabled in one context yet demonstrate surprising ability in another, challenging conventional scoring systems. Recognizing how functional and structural factors contribute to apparent frailty helps in setting realistic but ambitious goals for recovery.
Social determinants of health, including income level, access to transportation, living arrangements, and caregiver support, modulate the expression and impact of FND in the context of comorbidity. An older adult living alone with multiple medical conditions and functional gait disturbance may struggle to attend appointments, adhere to exercise programs, or obtain timely medication reviews. In contrast, someone with strong family support may be shielded from excessive exertion to the point of overprotection, reinforcing disability. Comorbid sensory impairments—such as hearing or vision loss—can further isolate individuals, heightening health anxiety and preoccupation with bodily symptoms.
The interaction between FND and comorbidities strongly influences responses to rehabilitation. Programs that address only the functional symptoms, without accounting for arthritis, cardiopulmonary limitations, or neuropathy, may be perceived as unrealistic or unsafe by patients and clinicians alike. Conversely, rehabilitation that focuses only on “organic” conditions may miss opportunities to challenge maladaptive patterns and fear-avoidance behaviors. Optimal outcomes typically require a nuanced approach in which therapists explicitly differentiate between what is structurally limited and what is functionally modifiable, helping older adults to test new movements in a graded, supported manner.
Medication review is a particularly important bridge between managing polypharmacy and supporting functional recovery. Rational deprescribing—carried out cautiously and collaboratively—can reduce dizziness, sedation, and cognitive fog that impede engagement in therapy. However, abrupt discontinuation of long-standing medications can provoke withdrawal effects or exacerbate anxiety, potentially worsening functional symptoms. Careful explanation, shared decision-making, and close follow-up are crucial when tapering drugs that were originally prescribed for misdiagnosed functional symptoms, such as antiseizure medications in the setting of dissociative attacks.
Communication among multiple specialists is another key determinant of how FND and comorbidities interact. Older adults often see cardiologists, endocrinologists, rheumatologists, psychiatrists, primary care clinicians, and various therapists. When FND is not clearly documented or when clinicians offer conflicting interpretations—one emphasizing “stroke,” another “stress,” and another “wear and tear”—patients may oscillate between explanations and treatment plans. This fragmentation can intensify symptom focus and erode trust. In contrast, when all team members share a coherent understanding of the functional diagnosis and its relationship to other conditions, it becomes easier to coordinate medication changes, prioritize interventions, and provide consistent messaging.
Risk assessment for serious organic disease remains essential, and the presence of FND should never preclude appropriate investigation of new symptoms. However, awareness of the typical patterns of interaction between FND, comorbidity, and polypharmacy allows clinicians to avoid over-testing and over-treatment. Repeated negative scans, prolonged telemetry, or invasive procedures not only consume resources but can also reinforce beliefs that something grave is being missed, entrenching health anxiety and reinforcing functional symptom cycles. Striking a balance between vigilance and restraint requires experience, clear communication, and, often, input from colleagues with specific expertise in FND in older adults.
Over time, the cumulative interaction of FND with other illnesses and medications can shape the trajectory of aging itself. Functional gait disturbance may hasten institutionalization in someone who already has mild cognitive impairment and limited social support. Persistent functional seizures may drive the decision to restrict driving or discontinue meaningful activities, even in the absence of epilepsy. Conversely, effective recognition and management of FND, integrated with attention to comorbidities and rationalization of polypharmacy, can preserve autonomy, reduce hospitalizations, and improve quality of life, even when significant structural disease is present.
Treatment adaptations and multidisciplinary care
Management strategies in later life need to be flexible, paced, and explicitly aligned with the person’s goals, values, and comorbidity profile. Interventions that are effective for younger people with functional neurological symptoms often require adaptation for older adults, particularly when there are sensory impairments, frailty, or mild cognitive changes. The emphasis shifts from short, intensive programs to carefully titrated, sustainable approaches that can be maintained within the constraints of aging, limited energy reserves, and the realities of home, community, or residential care settings.
A core principle is that treatment should be active and rehabilitative rather than purely supportive or palliative. Even in advanced age, functional symptoms are potentially reversible or at least modifiable, and clear communication of this potential is vital to counter pessimism and therapeutic nihilism. However, the pace and intensity of rehabilitation must be individualized. Highly demanding exercise regimens that might be appropriate for a younger adult can be overwhelming or unsafe in the context of frailty, cardiopulmonary disease, or severe arthritis. Instead, programs often focus on shorter, more frequent sessions, with rest breaks built in and explicit monitoring for fatigue, dizziness, or pain flare-ups.
Physical therapy tailored to functional motor symptoms is central, especially when mobility, gait, or balance are affected. Therapists familiar with FND use techniques that emphasize automatic, goal-directed movement rather than effortful, symptom-focused exercises. For older adults, this might involve practicing walking while talking, reaching for everyday objects, or navigating familiar home environments, rather than isolated strengthening drills. Strategies such as dual-task training, distraction, and rhythm-based movement can help bypass maladaptive movement patterns. At the same time, the therapist must account for genuine biomechanical and sensory limitations, incorporating aids such as walkers or orthotics judiciously to support safety without reinforcing dependency.
Occupational therapy plays an equally important role, particularly in preserving independence in activities of daily living and preventing institutionalization. Practitioners can help individuals experiment with new ways of performing tasks that have become difficult, such as dressing, bathing, or meal preparation, while gently challenging avoidance and fear-based behaviors. Home visits are especially valuable, allowing therapists to identify environmental hazards, optimize layout to support safe movement, and coach both patients and caregivers in strategies that encourage graded activity rather than overprotection. For those in long-term care, occupational therapists can facilitate participation in meaningful activities that reinforce a sense of identity and purpose beyond illness.
Speech and language therapy may be necessary when functional dysarthria, aphonia, stuttering, or dysphagia are present. In older adults, these symptoms often coexist with structural changes from stroke, degenerative disease, or prior head and neck surgery, requiring a nuanced blended approach. The therapist may use biofeedback, breathing exercises, and graded exposure to feared foods or speaking situations, while carefully coordinating with medical teams to ensure that swallowing is safe. Because fear of choking or “losing one’s voice” can be intense, psychoeducation about functional mechanisms is frequently integrated into sessions, helping individuals distinguish between genuine risk and learned avoidance.
Psychological interventions are a key component of multidisciplinary care, but they must be adapted to the cognitive, sensory, and cultural context of late life. Cognitive-behavioral therapy, for example, can be effective when modified to use simpler language, more repetition, and concrete, behaviorally focused strategies. Shorter sessions or telephone-based formats may be necessary for those with limited stamina or poor access to transportation. When cognition is significantly impaired, therapists may shift emphasis toward supporting caregivers, simplifying routines, and addressing environmental triggers for distress or functional exacerbations rather than expecting the patient to engage in complex cognitive restructuring.
Approaches that emphasize body awareness and regulation of arousal—such as relaxation training, breathing exercises, and mindfulness-based techniques—can be valuable in managing functional symptoms associated with anxiety, pain, or dissociation. However, these practices need to be carefully paced and framed to avoid reinforcing passivity or the belief that one must be entirely relaxed before moving. Older adults who are unfamiliar with psychological language or skeptical about mental health interventions may respond better when these techniques are presented as “stress management,” “nervous system retraining,” or “ways of helping the brain and body work together,” rather than as psychotherapy per se.
Medication management is another critical domain of treatment adaptation. Many individuals reach specialist services with extensive polypharmacy, including drugs prescribed for misdiagnosed functional seizures, parkinsonism, or unexplained dizziness. A structured medication review, ideally conducted by a geriatrician, clinical pharmacist, or primary care clinician in close communication with neurology and psychiatry, can identify agents that are unnecessary, duplicative, or harmful. Deprescribing must be gradual and collaborative, with clear explanations to reduce fears that stopping medications will “undo” control of presumed organic illness. Supporting information sheets, pill organizers, and involvement of family or caregivers can help maintain adherence to revised regimens and prevent abrupt, unsupervised changes.
Because treatment spans multiple domains, coordinated multidisciplinary teamwork is essential. Effective care typically involves neurologists, geriatricians, psychiatrists or psychologists, physical and occupational therapists, speech and language therapists, nurses, social workers, and, when appropriate, pain or palliative care specialists. Regular case conferences or virtual meetings can ensure that each discipline shares a common understanding of the diagnosis and treatment plan, avoiding contradictory messages. For example, while the rehabilitation team encourages gradual reduction of wheelchair use in safe contexts, medical providers must avoid simultaneously prescribing prolonged bed rest or strict activity restriction for nonspecific complaints that could be managed more dynamically.
Primary care clinicians often act as the anchor for ongoing management, especially once specialist rehabilitation is complete. They can help maintain consistent messaging about the nature of FND, monitor for emerging comorbid conditions, and coordinate referrals if symptoms flare. Written care plans, shared across providers and with the patient and family, can outline agreed strategies for responding to exacerbations—such as brief increases in physiotherapy, targeted psychological support, and medication review—without automatically resorting to emergency department visits or repeat imaging.
Family and caregiver involvement usually requires specific attention in later life. Spouses, adult children, or paid caregivers may unintentionally reinforce disability by providing excessive assistance, engaging in repetitive reassurance-seeking conversations, or avoiding any activity that might provoke symptoms. Education sessions that explain functional mechanisms, the rationale for graded exposure, and realistic expectations of improvement can help redirect support toward encouragement of independence. Caregivers may also need guidance in balancing safety with autonomy—allowing supervised practice of walking or transfers, for example, rather than insisting on wheelchair use at all times. Addressing caregiver stress, guilt, or frustration is important, as these emotional dynamics can influence the household environment and the patient’s engagement with treatment.
For some individuals, particularly those living alone or in resource-limited settings, community-based services and technology can extend the reach of multidisciplinary care. Home health teams can deliver elements of physical and occupational therapy in the home, while telehealth sessions allow follow-up with psychologists or neurologists without the burden of travel. Exercise programs delivered through community centers, senior groups, or virtual classes can provide both physical conditioning and social contact, which may reduce isolation and health anxiety. However, technology-based solutions must be matched to the person’s sensory capacities, digital literacy, and access to devices or internet connectivity.
Hospital-based rehabilitation units that specialize in FND may not always be accessible to older adults, especially those with multiple comorbidities or significant frailty. When inpatient rehabilitation is appropriate, admission criteria and program design need to acknowledge the realities of aging. Length of stay may need to be slightly longer to achieve gains safely, and there should be close medical oversight to manage exacerbations of heart failure, infections, or other intercurrent illnesses. Importantly, discharge planning should start early, with explicit focus on how improvements achieved in the structured inpatient environment will be supported and maintained at home or in long-term care.
Pain management strategies must be integrated into the overall plan rather than treated in isolation. For chronic pain that coexists with functional motor or sensory symptoms, multimodal programs that combine gentle physical conditioning, pacing, psychological approaches (such as acceptance and commitment strategies), and rationalized medication use tend to be more successful than repeated procedures or escalating analgesics. Older adults may benefit from learning to differentiate between “hurt” and “harm,” recognizing that some increase in discomfort during rehabilitative movement is not necessarily dangerous, especially when monitored by professionals who understand both FND and the person’s medical history.
When cognition is affected, either by FND-related mechanisms or by coexisting mild cognitive impairment or early dementia, interventions often require simplification and external supports. Therapists may use written step-by-step instructions, visual cues, and repetition to compensate for memory difficulties. Caregivers can assist with cueing and reinforcement of strategies outside therapy sessions. In some cases, cognitive rehabilitation techniques can be employed to help individuals manage attentional lapses and executive dysfunction that interfere with adherence to exercise or behavioral plans. Close coordination with neuropsychology services can clarify the extent and nature of cognitive deficits and guide the choice of appropriate adaptations.
Throughout the course of care, communication style strongly influences engagement and outcomes. Older adults may have experienced decades of mixed or stigmatizing messages about medically unexplained symptoms, leading to mistrust or resignation. Clinicians and therapists can foster collaboration by using clear, nonjudgmental language, explicitly validating that symptoms are real and distressing, and emphasizing that improvement is possible even when scans show age-related or chronic changes. Providing written summaries of the diagnosis, treatment goals, and self-management techniques can help counter memory lapses, reduce anxiety between visits, and support consistent understanding among family members and other professionals.
Managing relapses and fluctuations is an expected part of long-term care. Life events such as bereavement, hospitalization for unrelated illness, changes in living situation, or new medications can trigger temporary worsening of functional symptoms. Preparing individuals and their support networks for this possibility—normalizing that setbacks do not mean treatment has failed—can prevent cycles of panic and over-investigation. A pre-agreed plan might include brief booster sessions with rehabilitation therapists or psychologists, early contact with primary care for medication review, and time-limited use of assistive devices until confidence and function are restored.
Ultimately, successful treatment in this population is less about eliminating all symptoms and more about maximizing participation, autonomy, and quality of life within the constraints of aging and comorbidity. Multidisciplinary teams that integrate medical management, psychological support, and targeted rehabilitation can help older adults make meaningful gains, even when structural disease is present. By adapting interventions to individual capabilities and environments, and by maintaining coherent communication across providers, it becomes possible to reduce disability, prevent unnecessary escalation of care, and support people in remaining engaged in valued roles and activities for as long as possible.
Ethical, social, and quality-of-life considerations
Ethical questions often emerge from the very beginning of the diagnostic process, especially when symptoms are interpreted differently by various clinicians, family members, and the patient. Older adults may have undergone years of investigations before FND is proposed, and shifting from a presumed structural explanation to a functional one can feel like a profound redefinition of their illness identity. Ethically sound practice requires that this transition be handled with honesty and sensitivity: clinicians must acknowledge past uncertainties, avoid blaming the patient or previous providers, and clearly articulate why the new diagnosis is being made based on positive clinical signs rather than on exclusion or disbelief.
Respect for autonomy is central but can be complicated by fluctuating cognition, mild cognitive impairment, or evolving dementia. An older person may understand and agree with the FND diagnosis on one day and later express doubt or confusion. This raises questions about capacity to consent to specific interventions—particularly when treatment involves changes that feel risky, such as reducing long-standing medications or challenging entrenched avoidance behaviors. Clinicians must assess decision-making capacity in relation to the specific choices at hand, support understanding with repeated explanations and written materials, and involve trusted family members or legal proxies when necessary, while still prioritizing the person’s own preferences and values wherever possible.
Communication about FND can carry a high risk of stigma and perceived invalidation. Many older adults grew up in cultural contexts where mental health problems were seen as weakness or moral failing, and where phrases like “all in your head” were used dismissively. If FND is framed purely as a psychological or imaginary problem, patients may feel accused of malingering or exaggeration. Ethically responsible communication emphasizes that symptoms are real, involuntary, and disabling, and that they arise from altered brain–body functioning, not from deliberate control. Using metaphors—such as a “software rather than hardware” problem in the nervous system—can help convey legitimacy without resorting to dualistic or pejorative language.
Justice and equity considerations are magnified in later life, when ageism can subtly influence diagnostic and treatment decisions. Some older adults with FND are denied access to intensive rehabilitation, psychotherapy, or specialist consultation on the assumption that they are “too old to benefit,” even when evidence suggests that meaningful improvement is possible. Others may have their symptoms attributed to “just old age” or “wear and tear,” effectively blocking further assessment. Ensuring equitable care means actively countering these assumptions, applying the same standard of diagnostic rigor and treatment offer to older adults as to younger people, while tailoring goals to the individual’s health status, comorbidity, and priorities.
Resource allocation introduces further ethical complexity. Multidisciplinary FND services, long-term psychological support, and specialized rehabilitation can be costly and are often limited in availability. Decision-makers may question whether older adults, particularly those with significant comorbidities or limited life expectancy, should receive priority for such interventions. A principled approach balances considerations of benefit, burden, and fairness. Age alone should not be used as an exclusion criterion; instead, individualized assessments of potential gains in function, relief of distress, and prevention of downstream costs—such as falls, institutionalization, or repeated emergency visits—should inform allocation decisions.
Quality of life is a crucial outcome in this context and cannot be reduced to symptom counts alone. Many older people with FND value independence, ability to stay at home, social connection, and participation in meaningful roles—such as grandparenting or community involvement—at least as much as they value reduction in tremor, weakness, or seizures. Rehabilitation and support plans that focus narrowly on symptom elimination may miss what matters most to the person. Ethical care requires eliciting and revisiting these priorities, integrating them into goal setting, and being transparent when not all goals can be achieved due to physical limitations, environmental factors, or progressive illnesses.
Social isolation and loneliness often shape both the emergence and the impact of FND in later life. Widowhood, retirement, loss of peers, and reduced mobility can shrink social networks, leaving symptoms as one of the primary remaining sources of interaction with others. In some cases, increased contact with healthcare services may inadvertently become a substitute for other forms of social connection. Clinicians must navigate the boundary between providing needed medical care and avoiding iatrogenic reinforcement of illness-focused identity. Linking patients to community resources, peer support groups, or structured activity programs can help shift the center of gravity from the clinical setting back toward ordinary life.
Family dynamics and caregiving arrangements raise additional ethical concerns. Family members may experience frustration, skepticism, or burnout, especially if they have been told for years that tests are “normal” and are unsure how to respond to ongoing disability. Some may suspect voluntary exaggeration; others may become overprotective, restricting activity in ways that unintentionally intensify dependence and reduce quality of life. Providing families with accurate information about FND, involving them in goal setting, and offering space to articulate their own burdens and fears are critical to sustaining ethical, collaborative care. When disagreements arise—for example, if family members push for further investigations that clinicians judge unnecessary—open discussion, second opinions, and transparent documentation can help maintain trust.
The risk of coercion or subtle pressure can appear around certain treatment choices, particularly when safety is a concern. For instance, a team may recommend reducing use of a wheelchair or bed rest in favor of graded mobilization, while the person or family strongly fears falls or symptom exacerbation. In residential care, staff may prioritize efficiency and risk avoidance over autonomy, routinely using restraints or high levels of assistance that exceed what is strictly necessary. Ethically grounded practice seeks a balance between safety and self-determination: supporting mobility with appropriate safeguards, explaining the rationale for active rehabilitation, and avoiding punitive attitudes when patients find changes difficult or progress is slow.
Diagnostic labeling itself carries social and legal implications. Older adults with functional seizures may face driving restrictions, changes in insurance status, or employment consequences similar to those with epilepsy, even once the nonepileptic nature of events is recognized. Conversely, because FND is sometimes viewed as less “serious” than structural disease, disability benefits, accommodations, or home-care services may be harder to secure despite the presence of substantial functional impairment. Clinicians can play an advocacy role by carefully documenting the extent of disability, clarifying that symptoms are genuine and disabling, and supporting appeals or applications for appropriate supports when necessary.
Advance care planning and discussions about future care are often complicated by FND. When functional symptoms coexist with progressive illnesses—such as heart failure, advanced lung disease, or neurodegeneration—it can be hard for patients and families to distinguish which limitations are potentially modifiable and which reflect irreversible decline. Overly optimistic assurances that “it’s just functional” may lead to unrealistic expectations and delayed planning for long-term support needs. Conversely, framing everything as degenerative or “inevitable decline” can undermine motivation for rehabilitation and perpetuate suffering that might be alleviated. Ethically sound communication acknowledges both possibilities: some aspects may be improvable through therapy, while others may require adaptation, assistive devices, or supportive care.
Spiritual and existential dimensions are often salient for older adults, particularly when symptoms challenge their sense of identity, purpose, or control. People may question why they have become disabled despite “normal scans,” interpret symptoms through religious or moral frameworks, or worry that they are being punished or tested. Attentive listening, willingness to explore these meanings, and, when appropriate, collaboration with chaplaincy or spiritual care providers can support holistic well-being. Even simple practices—such as asking what gives the person a sense of meaning or comfort—can guide care plans that respect deeply held values and foster resilience.
The social environment beyond the family also shapes lived experience. Stigma from friends, neighbors, or community members may arise when others cannot see a clear physical cause on imaging or do not understand why the person appears disabled on some occasions yet more capable on others. Misunderstandings can lead to withdrawal from social activities, embarrassment, or efforts to hide symptoms, which in turn exacerbates isolation and depression. Public and professional education about FND, especially in settings serving older adults such as senior centers, long-term care facilities, and home health agencies, can mitigate misperceptions and promote supportive attitudes.
Transitions of care are a frequent source of ethical and social vulnerability. Hospitalizations for intercurrent illnesses, moves to assisted living or nursing homes, and changes of primary care physicians can all disrupt continuity of understanding about FND. New teams may question prior diagnoses, restart extensive workups, or give conflicting messages about prognosis and treatment. Ensuring that clear, respectful summaries of the diagnosis, prior assessments, and effective strategies accompany the patient across settings is essential for preserving dignity and avoiding avoidable distress. When possible, direct communication between sending and receiving clinicians can prevent misunderstanding and unnecessary duplication of investigations.
The cumulative effect of FND on quality of life can be substantial, even when structural disease is mild. Persistent fatigue, pain, weakness, or seizures can restrict travel, hobbies, volunteer work, and social engagement. Sleep disruption, fear of unpredictable episodes, and embarrassment about unusual movements or speech patterns often weigh heavily on emotional well-being. Systematic assessment of quality-of-life domains—mobility, self-care, interpersonal relationships, mood, role fulfillment, and sense of control—helps teams identify priority areas for intervention and gauge the impact of treatment beyond narrow symptom scales.
Ethical practice also requires vigilance about potential abuse, neglect, or exploitation. Older adults with visible disability, cognitive vulnerability, or high healthcare needs may be at greater risk of financial manipulation, emotional abuse, or inadequate care. Because FND can generate skepticism about the authenticity of symptoms, there is a particular danger that signs of neglect or mistreatment will be dismissed as “attention-seeking” or “behavioral.” Clinicians should remain alert to inconsistencies between reported support and observed conditions, unexplained injuries, or signs of fear around caregivers, and they should follow appropriate safeguarding or mandatory reporting procedures when concerns arise.
Involvement of patients and families in service design and research carries ethical and social significance. Older adults with FND have often felt marginalized by traditional medical models; inviting their perspectives on what constitutes meaningful outcomes, acceptable risks, and tolerable burdens can reshape clinical pathways and research priorities. Including individuals from diverse cultural, socioeconomic, and linguistic backgrounds helps ensure that care models address real-world barriers, such as transportation difficulties, limited digital literacy, or distrust of mental health services. By foregrounding lived experience, healthcare systems can develop interventions that not only reduce symptoms but also genuinely enhance autonomy, dignity, and day-to-day quality of life.
